Note 13 - Commitments and Contingencies (Details Textual) - USD ($) $ in Millions |
3 Months Ended | ||
|---|---|---|---|
Jan. 31, 2024 |
Apr. 30, 2024 |
Oct. 31, 2023 |
|
| Letters of Credit Outstanding, Amount | $ 8.5 | ||
| Standby Letters of Credit [Member] | |||
| Line of Credit Facility, Maximum Borrowing Capacity | 22.5 | ||
| Washington Department of Revenue Ruling [Member] | |||
| Payments for Sales Taxes | $ 1.8 | ||
| Washington Department of Revenue Ruling [Member] | General and Administrative Expense [Member] | |||
| Loss Contingency, Loss in Period | $ 3.5 | ||
| Accrued Liabilities and Other Liabilities [Member] | |||
| Self-insurance, Accrued Expenses for Health Claims Incurred But Not Reoprted | $ 1.5 | $ 1.2 |
| X | ||||||||||
- Definition The amount of cash outflow for sales taxes. No definition available.
|
| X | ||||||||||
- Definition The amount of accrued expenses for health claims incurred but not reported. No definition available.
|
| X | ||||||||||
- Definition The total amount of the contingent obligation under letters of credit outstanding as of the reporting date. No definition available.
|
| X | ||||||||||
- Definition Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|